http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2067395-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_464eb9068823683b5a4a63aa3cb13553
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-173
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 1993-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b824b051bd9dcce3135b022bacfc288
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ac259f3d9575c8a5e582cacbb273fcb
publicationDate 1995-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2067395-A1
titleOfInvention DERIVATIVES OF NUCLEOSIDES OR ANALOGS TO NUCLEOSIDES.
abstract DERIVATIVES OF NUCLEOSIDES OR ANALOGUES TO NUCLEOSIDES COMPRISING A NITROGEN BASE SELECTED AMONG ADENINE, GUANINE, CYTOSINE, URACIL AND THYMINE, AND HAVING THE GENERAL FORMULA I: NU-O-FA IN WHICH O REPRESENTS AN OXYGEN ATOM, NU IS AN NUCLEOSIDE OR ANALOGUE TO NUCLEOSIDE AND FA IS AN ACYL GROUP OF A MONO-UNSATURATED C18 TO C20 FATTY ACID, ESTERIFIED WITH A HYDROXYL GROUP IN POSITION 5" FROM THE SUGAR REMAIN OF THE NUCLEOSIDE OR WITH A HYDROXYL GROUP FROM THE NON-CYCLIC CHAIN OF ANALOGUE A NUCLEOSIDE ALSO DISCLOSED PHARMACEUTICAL AND VETERINARY ANTI-VIRAL COMPOSITIONS COMPRISING A COMPOUND OF FORMULA I ALONE OR IN COMBINATION WITH A PHARMACEUTICALLY ACCEPTABLE CARRIER THESE DERIVATIVES AND COMPOSITIONS ARE USEFUL FOR TREATING A HUMAN OR ANIMAL PATIENT SUFFERING FROM A VIRAL INFECTION AND FOR REDUCE THE INFECTIOUS LOAD.
priorityDate 1993-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8807532-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0350287-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0056265-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID597

Total number of triples: 30.